Amazon.com, Inc. (AMZN) announced Wednesday it's scaling up its pharmacy ambitions in a big way, planning to expand same-day prescription delivery to nearly 4,500 U.S. cities and towns by the end of 2026. That's almost 2,000 new communities getting access to medication delivery that actually arrives when you need it.
The expansion specifically targets areas that have become pharmacy deserts—places where closures, staffing shortages, and transportation barriers make getting prescriptions genuinely difficult. States like Idaho and Massachusetts will be newly included in the rollout, giving residents there the kind of access that's been available in larger metro areas.
"Patients shouldn't have to choose between speed, cost, and convenience when it comes to their medication, regardless of where they live," said John Love, Vice President of Amazon Pharmacy.
Following the Money and the Momentum
Amazon's pharmacy business had a strong 2025, with Prime members saving over $150 million through manufacturer-sponsored coupons alone. The company's prescription savings program delivers discounts up to 80% on generic medications and 40% on brand-name drugs for Prime members.
Last year also saw Amazon introduce a caregiver support feature and expand its RxPass program, which gives Prime members access to more than 50 commonly prescribed medications for $5 per month. Combined with 24/7 access to pharmacists and reliable delivery, it's a package designed to compete directly with traditional pharmacy chains.
The strategy is clearly about capturing market share in underserved areas while leveraging Amazon's existing logistics infrastructure. Prime members already benefited from record-breaking delivery speeds in 2025, and extending that capability to prescriptions creates another reason to stay in the ecosystem.
Stock Performance and Valuation
Despite the pharmacy expansion news, Amazon shares closed down 1.51% at $203.84 during Wednesday's regular trading session. The stock has been facing headwinds lately, with momentum metrics showing underperformance relative to the broader market.
From a fundamental perspective, Amazon trades at a premium valuation compared to peers, though its balance sheet remains solid. The company continues to invest heavily in new initiatives like pharmacy services while managing profitability across its core e-commerce and cloud businesses.
